Internationale Partnersuche

Forschung & Entwicklung Anfrage

A Moldovan medical center is looking for research partners in the area of developing a new approach for treatment and progression prevention of acquired myopia

Country of Origin: Moldova
Reference Number: RDMD20170616001
Publication Date: 20 July 2017

Summary

A medical center from Republic of Moldova has developed a treatment and progression prevention of acquired myopia.
The center is interested in establishing partnerships with similar organizations in the research area mentioned above to evaluate the efficiency of treatment and progression prevention of acquired myopia through physio-therapeutic treatment and refractive therapy applied combined.

Description

Ophthalmology is the priority direction in the activity of the Moldovan medical center, which has become a reference institution for addressing visual disorders. Within the center, among the multitude of services offered, patients benefit from specialized ophthalmic services, exclusive diagnostic methods, methods of treatment and prophylaxis of myopia progress, physical therapy treatment, laser surgical treatment of the ocular globe and limfatic driving-organism toxin elimination.

One of the main directions on which the specialists of the center are focused is progression of myopia which can lead to important irreversible changes of the eye resulting in eyesight loss. 

Due to an increased incidence of myopia and an obvious tendency to increase in the last 10-20 years, the need of discovering new prophylaxis methods of myopia development and progression has emerged. 

The treatment consists of a ten day daily physio-therapeutic complex of procedures. During the 10 (ten) day treatment period, the general biologically active point of the eye are electrically stimulated for 1 minute (one point at a time) each day. Then, the same procedure is applied on the eye local acupuncture points. The following step consists of  a 4 (four) minute ciliar muscle stimulation using helium-neon laser radiation of  low intensity. After the completion of the 10 day treatment described above, 1 year of refractive therapy (Corneal Refractive Therapy - CRT) follows.  

The procedure is patented by the Moldovan medical center who is looking for research partners to evaluate the efficiency of treatment and progression prevention of acquired myopia through physio-therapeutic treatment and refractive therapy applied combined.

Advantages and Innovations

Scientific novelty and originality 

1.	The combined physio-therapeutic treatment of acquired myopia - electropuncture and ciliary muscle stimulation by infrared laser was applied in the ophthalmologic practice for the first time.

2.	The combined treatment of acquired myopia- physiotherapeutic methods and refractive therapy were applied in the ophthalmologic practice for the first time.

The Medical Center provides the following advantages to potential partners:

1.	Demonstrated  technology feasibility in the chosen research area(treatment and progression prevention of acquired myopia). The proposed research was initiated and we already have the primary results, which were published in scientific journals. Two patents were granted for the invention of the treatment methods.

2.	Access to a sufficient number of patients to conduct the clinical studies.

3.	Up-to-date equipment for research and investigations. 

4.	Skilled ophthalmologists-researchers.

5.	Experience in project management and implementation.

Stage Of Development

Field tested/evaluated

Stage Of Development Comment

Initial proof-of-concept studies have demonstrated the technology feasibility.

Requested partner

The medical center from Republic of Moldova is looking for a partner that have access to patients with pathology of refraction (myopia). The partner entity should have experience of running clinical research. It is envisaged that the partnership will take the form of a research cooperation, with funding opportunities under the Horizon 2020 programme being actively explored, a technical cooperation agreement or a services agreement.

The company is looking for partners for common investigation. Therefore the company offers a research cooperation agreement to partners who want to implement joint research projects or clinical studies